Article Text

PDF
Review: lifestyle or pharmacological interventions prevent or delay type 2 diabetes in impaired glucose tolerance

Statistics from Altmetric.com


 
 Q In persons with impaired glucose tolerance, do lifestyle or pharmacological interventions prevent or delay type 2 diabetes mellitus (DM)?

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★★☆ Endocrine ★★★★★★☆ Obesity—physician ★★★★★★☆

METHODS

Embedded ImageData sources:

Medline (1966 to July 2006), EMBASE/Excerpta Medica (1980 to July 2006), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews (Issue 2, 2006), references of relevant articles, and experts in the field.

Embedded ImageStudy selection and assessment:

randomised controlled trials (RCTs) that evaluated an intervention to delay or prevent type 2 DM in persons with impaired glucose tolerance and had an outcome measurement of diabetes. 21 RCTs met the selection criteria, and 17 RCTs …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.